Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules.

Authors:
Elizabeth J de Koster Olga Husson Eveline W C M van Dam G Sophie Mijnhout Romana T Netea-Maier Wim J G Oyen Marieke Snel Lioe-Fee de Geus-Oei Dennis Vriens

Endocr Connect 2022 Aug 19;11(8). Epub 2022 Jul 19.

Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Objective: This study assessed the health-related quality of life (HRQoL) in patients undergoing 2-[18F]fluoro-2-deoxy-D-glucose (FDG)-PET/CT for an indeterminate (Bethesda III/IV) thyroid nodule. FDG-PET/CT accurately rules out malignancy and prevents 40% of futile diagnostic surgeries in these nodules.

Design: Secondary analyses of HRQoL data from a randomised controlled multicentre trial (NCT02208544) in 126 patients from 15 hospitals in the Netherlands were done.

Methods: Longitudinal HRQoL assessment was performed using the EuroQol 5-dimension 5-level (EQ-5D-5L), the RAND 36-item Health Survey v2.0 (RAND-36), and the Thyroid Patient-Reported Outcome (ThyPRO) questionnaire on baseline, 3, 6, and 12 months, relative to the date of the FDG-PET/CT scan.

Results: Patients who were randomised to active surveillance following an FDG-negative nodule instead of diagnostic surgery reported stable HRQoL scores throughout the year. Univariate analysis indicated better HRQoL for patients undergoing surveillance than surgical patients with benign histopathology on multiple physical and psychosocial domains. Univariate within-group analysis suggested both temporary and continued HRQoL deteriorations in patients with benign histopathology over time. Multivariate within-group analysis demonstrated no significant longitudinal HRQoL changes in patients undergoing active surveillance. In contrast, in patients with benign histopathology, worse HRQoL was observed with regard to ThyPRO cognitive impairment (P = 0.01) and cosmetic complaints (P = 0.02), whereas goitre symptoms (P < 0.001) and anxiety (P = 0.04) improved over time. In patients with malignant histopathology, anxiety also decreased (P = 0.05).

Conclusions: The reassurance of a negative FDG-PET/CT resulted in sustained HRQoL throughout the first year of active surveillance. Diagnostic surgery for a nodule with benign histopathology resulted in more cognitive impairment and physical problems including cosmetic complaints, but improved goitre symptoms and anxiety. Anxiety was also reduced in patients with malignant histopathology.

Download full-text PDF

Source
http://dx.doi.org/10.1530/EC-22-0014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346328PMC
August 2022

Publication Analysis

Top Keywords

benign histopathology
16
patients undergoing
12
active surveillance
12
patients benign
12
patients
10
hrqol
9
cognitive impairment
8
hrqol patients
8
goitre symptoms
8
within-group analysis
8
cosmetic complaints
8
diagnostic surgery
8
malignant histopathology
8
patients malignant
8
quality life
8
longitudinal hrqol
8
health-related quality
8
histopathology
6
fdg-pet/ct
5
benign
4

Keyword Occurance

Similar Publications

Pediatric Bladder Tumors: A Ten-Year Retrospective Analysis.

Authors:
Andrew D Shumaker Miriam Harel Jordan Gitlin Steven C Friedman Lori Dyer Jaime Freyle Paul F Zelkovic Mark Horowitz Ronnie G Fine Richard N Schlussel

Urology 2022 Aug 12. Epub 2022 Aug 12.

Pediatric Urology Associates, P.C. Tarrytown, NY, USA.

Objective: To present our experience in a single pediatric urology practice over a ten-year period with bladder tumors in the pediatric population in an effort to add to the relatively small amount of existing data. We hope to expand the community's knowledge of presentations, management and natural history of pediatric bladder tumors.

Methods: We retrospectively queried our electronic medical records for ICD-10 and CPT codes relevant for bladder tumors. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Primary seminal vesicle epithelioid smooth muscle neoplasm of uncertain biologic potential.

Authors:
Charlotte Roy Douglas Drover Andrea Simmonds

Can J Urol 2022 Aug;29(4):11266-11269

Memorial University of Newfoundland, St. John's, Newfoundland, Canada.

We present the case of a 73-year-old male patient who presented with obstructive urinary symptoms, pelvic pressure, and hematuria. CT imaging revealed a heterogenous prostate enlargement, and MRI demonstrated the mass to be arising from the seminal vesicle. Prostate biopsies showed benign tissue. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Gas-Containing Biliary Calculi: Case Series and a Systematic Review.

Authors:
Sergio Huerta Rasha Kakati Heather Lanier

Am Surg 2022 Aug 15:31348221121553. Epub 2022 Aug 15.

University of Texas Southwestern Medical School, Dallas, TX, USA.

Background: Cholelithiasis is a common gallbladder finding leading to cholecystitis in 7% of cases. Sonographic imaging or computed tomography scans are commonly employed for the diagnosis of benign gallbladder disease. Air within the gallbladder might carry various diagnoses. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Sporadic and Familial Adenomatous Polyposis-associated Foveolar-type Adenoma of the Stomach.

Authors:
Tomoaki Naka Taiki Hashimoto Hourin Cho Noriko Tanabe Teruhiko Yoshida Yasushi Yatabe Takaki Yoshikawa Seiichiro Abe Shigeki Sekine

Am J Surg Pathol 2022 Aug 15. Epub 2022 Aug 15.

Department of Diagnostic Pathology.

Gastric foveolar-type adenoma (FA) is a rare benign neoplasm occurring either sporadically or in patients with familial adenomatous polyposis (FAP). However, the molecular features of FA and the relationship between sporadic and syndromic lesions remain unclear. In this study, we performed clinicopathological, immunohistochemical, and genetic analyses of 18 sporadic and 30 FAP-associated FAs. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Malignant juxtaglomerular cell tumor.

Authors:
Daniel Geisler Fawaz Almutairi Ivy John Gabriela Quiroga-Garza Michelle Yu Raja Seethala Sheldon Bastacky

Urol Case Rep 2022 Nov 31;45:102176. Epub 2022 Jul 31.

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Juxtaglomerular cell tumors (JGCTs) are rare, typically benign neoplasms; only rare cases are clinically or histologically malignant. We herein report the histologic, immunophenotypic, and molecular features of a clinically unsuspected, diagnostically challenging case of malignant JGCT in a 23-year-old man. The diagnosis is confirmed with electron microscopy. Read More

View Article and Full-Text PDF
November 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap